Bally Ribbon Mills Offers Custom-Designed Woven Materials for Critical Rigging and Tie Down Applications

Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment

Monon Bioventure receives funding to develop Purdue-discovered glioblastoma treatment

Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts

Alfa Chemistry Offers Abundant Choices of Alternative Energy Materials for Energy Storage & Batteries

Quanticate partners with Cancer Research UK to launch DETERMINE Study

Vyasa Adds Real-Time Dashboards to Layar Data Fabric

Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today introduces its latest application interface, Signal. Featuring an intuitive design, Signal enables users to monitor trends and identify anomalies in their Layar data fabric through highly-visual charts and graphs delivered in a single dashboard.

Bora Pharmaceuticals partners with TaiRx, Inc. to manufacture breakthrough anticancer drug

Integrated DNA Technologies Launches New PrimeTime™ qPCR One-Step Master Mix with Exclusive Mutant Enzyme

BioIVT Acquires Fidelis Research

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Abzena strengthens R&D capabilities to support rapid antibody discovery

For further information, images, and interview opportunities, please contact Kristy Harmer at ramarketing: kristy.harmer@ramarketingpr.com | +44 (0)191 222 1242 | ramarketingpr.com | Twitter: @ramarketingpr | Facebook: /ramarketingpr | Linkedin: /ramarketing About Abzena Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.

Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research

Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection

CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery

DDA Platform Offers A Wide Range of in Vitro and in Vivo Assays to Cover Early Stage Drug Discovery

Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening

Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant

Scitara announces partnership with Agilent to benefit customers with enhanced digital lab connectivity

Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery

Connect in Pharma provided a platform where key players in European pharma found innovative, patient-centric and sustainable solutions for strengthening the pharmaceutical supply chain.